Sarnat Staging as Clinical Prognostic Tool to Assess Neurodevelopmental Outcome at 24 months of Age in Full Term Infants Treated with Therapuetic Hypothermia for Hypoxic Ischemic Encephalopathy (563)
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: Assess whether Sarnat staging could predict neurodevelopmental outcome at 24 months of age.
Background: Sarnat staging as neurodevelopmental predictor during therapeutic hypothermia treatment for hypoxic ischemic encephalopathy are currently minimal.
Design/Methods: Retrospective chart review of full-term infants admitted to Morristown Medical Center’s Neonatal Intensive Care Unit from January 2014 – December 2017 that underwent therapeutic hypothermia for suspected HIE. Infants were retrospectively assigned Sarnat scores and classified as mild, moderate, or severe encephalopathy during treatment, post-treatment, and discharge. Developmental data was retrospectively collected at 24mo using Gesell Developmental Assessment Tool.
The raw Gesell score was expressed as a developmental quotient (tested age/actual age). The effect of Sarnat stage on DQ was assessed by multiple regression analysis with DQ as the dependent variable, and gestational age, birth weight, gender, 1- and 5-minute Apgar scores as independent variables.
Results: 23 full-term infants were collected. Developmental data at 24mo and Sarnat scores were available for 14 infants. Mean (SD) birth weight was 3.3 kg (0.47), gestational age 39.0w (0.6), and Apgars 2 (0.75 – 3, median, IQR), 3.5 (1.5 – 5), and 5 (4 – 5) at 1, 5, and 10 minutes. All infants required positive pressure ventilation and 6/14 (43%) required chest compressions at delivery.
The DQ at 24mo significantly correlated with severity of Sarnat score pre-cooling (p = 0.024), as well as days 1 (p=0.038), 2 (p=0.023), and 3 (p=0.023) during cooling; however, not on days 1 (p=0.097), 2 (p=0.11), or 4 (p = 0.061) post-cooling. The Gesell subscales least correlating with Sarnat scores were expressive language and social skills, which were only significant at pre-cooling (p=0.018 and p=0.021).
Conclusions: Sarnat staging continues to be a powerful predictor of long-term neurodevelopment before and during therapeutic hypothermia treatment. This finding may be important in low-resource settings where other potential predictors of long-term outcome may be unavailable.
Disclosure: Dr. Gordon has nothing to disclose. Dr. Griffin has nothing to disclose. Dr. Bennett has nothing to disclose.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.